Our work

On this page you will find a collection of our company output.

 

t
Filter:
Vaccine2023

Cost-effectiveness of the COVID-19 vaccine of Fall 2023

With the right pricing, the XBB1.5 updated mRNA-1273.222 vaccine offers substantial health and economic benefits. A critical consideration for future vaccination strategies.

Scientific paper

COVID-19

Vaccination
Screenshot 2025-04-16 140620

Cost-effectiveness of Nirsevimab for RSV

As this RSV season’s immunization window closes, it's time to look ahead. Evidence confirms that nirsevimab can be a cost-effective solution for preventing RSV infections in Dutch infants.

Scientific paper

Vaccination

Economic evaluation of baloxavir marboxil for Influenza

We found that mRNA-1273 could prevent thousands of COVID-19 cases and save millions in healthcare costs. Our study supports it as the smart, cost-effective choice for protecting high-risk groups in the Netherlands.

Scientific paper

Influenza
Paper CKD

Cost-effectiveness of empagliflozin for CKD

We found that adding empagliflozin to standard care for chronic kidney disease (CKD) patients is likely cost-saving in the Netherlands, supporting broad implementation highlighting its value in achieving both clinical and economic goals. 

Scientific paper

CKD

Cost-effectiveness of high-dose influenza vaccination

Switching to high-dose flu vaccines for adults 60+ in the Netherlands is highly cost-effective. With strong public health impact and full cost-effectiveness at current pricing, HD-QIV is a smart upgrade to the national flu campaign.

Scientific paper

Influenza

Cost-Effectiveness of RDTs for Febrile Illness in Africa

Rapid diagnostic tests (RDTs) can significantly reduce unnecessary antibiotic use in low-resource settings—at minimal cost. Adding CRP testing to malaria diagnostics boosts prescribing confidence and offers a cost-effective strategy to fight antimicrobial resistance.

Scientific paper

Febrile Illness
draigon_logo

DRAIGON project

DRAIGON is a cutting-edge European initiative developing AI-driven diagnostics to detect antimicrobial resistance quickly and accurately. The technology combines genome sequencing with real-time analytics to support faster, smarter infection treatment.

Project

Anti-microbial resistance
DELPHI

DELPHI project

By automating the generation of 3D models of patient cancer-driving proteins, DELPHI promises earlier diagnosis, targeted interventions, and improved patient outcomes.

Project

Lung cancer

Diagnostics

Manifest obesity

A short and attractive description of what this project/publication is about, making sure people will click through to the next page.

Manifest

Obesity

Screenshot 2025-06-10 151752

Cost comparison of SMA treatments

One-time treatment with an upfront cost that provides a lifetime treatment effect for Spinal Muscular Atrophy (SMA) patients can save substantial healthcare costs when replacing a chronic lifelong treatment.

Scientific paper

SMA

DELSIS project

A short and attractive description of what this project/publication is about, making sure people will click through to the next page.

Project

Self-management

Cost-Effectiveness of Test-and-Treat Strategies

A short and attractive description of what this project/publication is about, making sure people will click through to the next page.

Scientific paper

Cost of Illness Analysis of Invasive Meningococcal Disease

A short and attractive description of what this project/publication is about, making sure people will click through to the next page.

Scientific paper

Invasive Meningococcal Disease

Economic evaluations of screening programs for chronic kidney disease

A short and attractive description of what this project/publication is about, making sure people will click through to the next page.

Scientific paper

CKD